Chugai Pharmaceutical Co., Ltd. (TYO:4519)
Japan · Delayed Price · Currency is JPY 6,806.00
-384.00 (-5.34%)
Nov 6, 2026, 3:30 PM JST
Chugai Pharmaceutical Financials Overview
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,414,375 | 1,257,941 | 1,170,611 | 1,111,367 | 1,259,946 | 999,759 |
Revenue Growth | 16.53% | 7.46% | 5.33% | -11.79% | 26.02% | 27.04% |
Gross Profit Gross Profit Growth | 1,010,715 | 894,251 | 831,202 | 698,061 | 783,695 | 661,612 |
Operating Income Operating Income Growth | 682,867 | 598,833 | 542,003 | 439,174 | 533,309 | 421,897 |
Net Income Net Income Growth | 503,712 | 434,012 | 387,317 | 325,472 | 374,429 | 302,995 |
Earnings Per Share EPS Growth | 306.09 | 263.72 | 235.36 | 197.80 | 227.57 | 184.17 |
EPS Growth | 26.83% | 12.05% | 18.99% | -13.08% | 23.57% | 41.09% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Domestic Oncology Domestic Oncology Growth | - | 246,500 | 247,700 | 260,200 | 256,000 | 261,500 |
Domestic Specialty Domestic Specialty Growth | - | 225,800 | 213,400 | 297,800 | 398,600 | 257,400 |
Overseas Overseas Growth | 655,000 | 605,400 | 536,800 | 416,500 | 384,600 | 283,900 |
Royalties and Other Operating Income Royalties and Other Operating Income Growth | 224,400 | 180,100 | 172,700 | 136,900 | 128,600 | 196,900 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 868,995 | 979,696 | 996,345 | 738,982 | 503,107 | 471,970 |
Total Debt Total Debt Growth | - | 25,710 | 10,897 | 13,455 | 14,109 | 16,040 |
Net Cash (Debt) Net Cash Growth | 868,995 | 953,986 | 985,448 | 725,527 | 488,998 | 455,930 |
Net Cash Growth | -1.52% | -3.19% | 35.83% | 48.37% | 7.25% | 24.12% |
Net Cash Per Share Net Cash Per Share Growth | 528.06 | 579.67 | 598.82 | 440.92 | 297.20 | 277.12 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 435,432 | 386,280 | 447,600 | 409,925 | 244,112 | 279,626 |
Capital Expenditures CapEx Growth | -74,149 | -76,273 | -50,415 | -71,948 | -62,625 | -65,969 |
Free Cash Flow Free Cash Flow Growth | 361,283 | 310,007 | 397,185 | 337,977 | 181,487 | 213,657 |
Free Cash Flow Growth | 3.12% | -21.95% | 17.52% | 86.23% | -15.06% | 44.37% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 71.46% | 71.09% | 71.01% | 62.81% | 62.20% | 66.18% |
Operating Margin | 48.28% | 47.60% | 46.30% | 39.52% | 42.33% | 42.20% |
Pretax Margin | 49.76% | 47.52% | 46.39% | 39.93% | 42.16% | 41.95% |
Profit Margin | 35.61% | 34.50% | 33.09% | 29.29% | 29.72% | 30.31% |
FCF Margin | 25.54% | 24.64% | 33.93% | 30.41% | 14.40% | 21.37% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 132.000 | 122.000 | 98.000 | 80.000 | 78.000 | 76.000 |
Dividend Per Share Growth | -51.47% | 24.49% | 22.50% | 2.56% | 2.63% | 38.18% |
Dividend Yield | 1.94% | 1.48% | 1.40% | 1.50% | 2.32% | 2.04% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 22.24 | 31.26 | 29.74 | 27.00 | 14.80 | 20.27 |
Forward PE | 20.00 | 29.02 | 29.26 | 26.55 | 18.61 | 22.33 |
P/FCF Ratio | 30.99 | 43.76 | 29.00 | 26.01 | 30.53 | 28.74 |
PS Ratio | 7.92 | 10.78 | 9.84 | 7.91 | 4.40 | 6.14 |